Journal of cataract and refractive surgery · 2012
Refractive outcomes of laser-assisted subepithelial keratectomy for myopia, hyperopia, and astigmatism using a 213 nm wavelength solid-state laser.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shah Sunil, Sheppard Amy L, Castle Jennifer, Baker David, Buckhurst Phillip J, Naroo Shehzad A, Davies Leon N, Wolffsohn James S
Аннотация
PURPOSE: To study the visual and refractive outcomes after laser-assisted subepithelial keratectomy (LASEK) performed with a 213 nm solid-state laser for a broad range of refractive errors.
SETTING: Private practice, Jersey, United Kingdom.
DESIGN: Case series.
METHODS: The LASEK was performed using a Pulzar Z1 213 nm solid-state laser. Manifest refraction and uncorrected (UDVA) and corrected (CDVA) distance visual acuities were measured preoperatively and 2 and 6 months postoperatively. Accuracy, safety, efficacy, and stability were assessed at 6 months.
RESULTS: The study enrolled 245 eyes (134 patients). The preoperative spherical equivalent (SE) refractive errors ranged from -9.50 to +6.50 diopters (D); 24 eyes had more than 2.50 D of astigmatism. At 6 months, 60.4% of eyes were within ±0.25 D of the intended SE, 89.4% were within ±0.50 D, and 97.9% were within ±1.00 D. No eye lost 2 or more lines of CDVA; 95.5% of eyes were unchanged or gained 1 line. The mean cylinder power decreased from -0.98 ± 1.17 D to -0.14 ± 0.28 DC at 6 months. The mean SE was unchanged over the follow-up period; -0.01 ± 0.57 D and -0.01 ± 0.55 D at 2 months and 6 months, respectively.
CONCLUSION: Laser-assisted subepithelial keratectomy performed using the 213 nm wavelength solid-state laser was safe, accurate, and effective for the treatment of myopia, hyperopia, and astigmatism.
FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.
SETTING: Private practice, Jersey, United Kingdom.
DESIGN: Case series.
METHODS: The LASEK was performed using a Pulzar Z1 213 nm solid-state laser. Manifest refraction and uncorrected (UDVA) and corrected (CDVA) distance visual acuities were measured preoperatively and 2 and 6 months postoperatively. Accuracy, safety, efficacy, and stability were assessed at 6 months.
RESULTS: The study enrolled 245 eyes (134 patients). The preoperative spherical equivalent (SE) refractive errors ranged from -9.50 to +6.50 diopters (D); 24 eyes had more than 2.50 D of astigmatism. At 6 months, 60.4% of eyes were within ±0.25 D of the intended SE, 89.4% were within ±0.50 D, and 97.9% were within ±1.00 D. No eye lost 2 or more lines of CDVA; 95.5% of eyes were unchanged or gained 1 line. The mean cylinder power decreased from -0.98 ± 1.17 D to -0.14 ± 0.28 DC at 6 months. The mean SE was unchanged over the follow-up period; -0.01 ± 0.57 D and -0.01 ± 0.55 D at 2 months and 6 months, respectively.
CONCLUSION: Laser-assisted subepithelial keratectomy performed using the 213 nm wavelength solid-state laser was safe, accurate, and effective for the treatment of myopia, hyperopia, and astigmatism.
FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.